| Market Cap | 430K 384K 355K 321K 601K 40.8M 611K 4.27M 1.69M 21.38M 1.61M 1.58M 67.4M | P/E 2018 |
-21.3x | P/E 2019 | -0.95x |
|---|---|---|---|---|---|
| Enterprise Value | 1.53M 1.36M 1.26M 1.14M 2.13M 145M 2.17M 15.15M 6M 75.9M 5.73M 5.61M 239M | EV / Sales 2018 |
949,389,161x | EV / Sales 2019 | 25,985,979x |
| Free-Float |
54.42% | Yield 2018 * |
-
| Yield 2019 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 39.93K | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -0.98% | +2.17% | +37.02% | +69.16% | 444.85B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 0.05 0.05 0.04 0.04 0.07 4.87 0.07 0.51 0.2 2.55 0.19 0.19 8.05 | 0.3 0.27 0.25 0.23 0.42 28.78 0.43 3.01 1.19 15.08 1.14 1.11 47.54 |
| Net income | -2.23M -1.99M -1.84M -1.67M -3.12M -212M -3.17M -22.12M -8.76M -111M -8.36M -8.19M -349M | -6.85M -6.11M -5.65M -5.12M -9.58M -650M -9.73M -67.96M -26.91M -340M -25.69M -25.15M -1.07B |
| Net Debt | -161K -143K -132K -120K -225K -15.24M -228K -1.59M -631K -7.99M -603K -590K -25.18M | 1.1M 979K 904K 820K 1.53M 104M 1.56M 10.88M 4.31M 54.53M 4.11M 4.03M 172M |
Employees
-
Sector
Pharmaceuticals
